Emerging therapeutics for the treatment of Friedreich’s ataxia
| Autor: | Sylvia Bösch, Elisabetta Indelicato |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
0301 basic medicine
congenital hereditary and neonatal diseases and abnormalities medicine.medical_specialty Ataxia business.industry Health Policy nutritional and metabolic diseases nervous system diseases 03 medical and health sciences Dysarthria 030104 developmental biology 0302 clinical medicine Physical medicine and rehabilitation Gait (human) Medicine Pharmacology (medical) medicine.symptom business human activities Pharmacology Toxicology and Pharmaceutics (miscellaneous) 030217 neurology & neurosurgery |
| Zdroj: | Expert Opinion on Orphan Drugs. 6:57-67 |
| ISSN: | 2167-8707 |
| DOI: | 10.1080/21678707.2018.1409109 |
| Popis: | Introduction: Friedreich ataxia (FRDA) is an autosomal recessive disorder which manifests with progressive instability, leading ultimately to loss of independent gait, dysarthria, skeletal abnormal... |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|